Results 201 to 210 of about 143,935 (260)
Dietary NA restriction converts the effect of NAMPT inhibition from cytostatic to cytotoxic in SCLC in vivo. ABSTRACT Small‐cell lung cancer (SCLC) is an aggressive malignancy with limited therapeutic options. We previously showed that nicotinic acid riboside (NAR) sustains NAD biosynthesis in vivo and compensates for NAMPT inhibition in SCLC models ...
Kyoji Tsurumi +12 more
wiley +1 more source
Prussian Blue Nanozyme Potentiates Venetoclax Efficacy in Acute Myeloid Leukemia by Inducing a More Mature Phenotype. [PDF]
Yang F +10 more
europepmc +1 more source
Integrating ex vivo drug sensitivity and genetic mutation analysis improves prediction of chemotherapy response in acute myeloid leukemia. [PDF]
Li W +13 more
europepmc +1 more source
Dual-target CAR-T cell therapy: latest updates from the 2025 ASH annual meeting. [PDF]
Feng S, Kong R, Xiao L, Zhou X.
europepmc +1 more source
A 3‐year‐old girl with a left optic nerve tumor
Brain Pathology, EarlyView.
Samuel López Muñoz +10 more
wiley +1 more source
P300/CBP inhibition with inobrodib in combination with gilteritinib and venetoclax targets leukemia stem cells in epigenetic mutant AML. [PDF]
Goetz ML +8 more
europepmc +1 more source
Very Late Extramedullary Relapse of Acute Myeloid Leukemia 13 Years After Allogeneic Transplant: A Case Report. [PDF]
von Aarburg Y +9 more
europepmc +1 more source

